Virginia Regulatory Town Hall
Department of Health Professions
Department of Health Professions
Regulations Governing the Prescription Monitoring Program [18 VAC 76 ‑ 20]
Action is Exempt from Article 2 of the Administrative Process Act
Definition of covered substances
Action 5088
General Information
Action Summary On July 1, 2018, the Code was changed to include the following in the covered substances that must be reported to the Prescription Monitoring Program: 1) Schedule V drugs for which a prescription is required; 2) the drug naloxone; and 3) cannabidiol oil or THC-A oil dispensed by a pharmaceutical processor in Virginia.
Chapters Affected Only affects this chapter.
Executive Branch Review This Action is exempt from Article 2 of the Administrative Process Act. The normal executive branch review process is not required. As such, it can be submitted directly for publication and is effective upon publication.
Exempt Citation: 2.2-4006
RIS Project Yes  [005571]
Associated Mandates Addition of covered substances to Prescription Monitoring Program
New Periodic Review This action will not be used to conduct a new periodic review.
Stages associated with this regulatory action.
Stage ID Stage Type Status
8337 Final Stage complete. This regulation became effective on 10/03/2018.
Contact Information
Name / Title: Ashley Carter  / Program Manager
Address: 9960 Mayland Drive
Suite 300
Richmond, VA 23233-1463
Email Address:
Phone: (804)597-4282    FAX: ()-    TDD: ()-

This person is the primary contact for this chapter.